Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.55 in the prior trading day, Origin Materials Inc (NASDAQ: ORGN) closed at $1.44, down -7.10%. In other words, the price has decreased by -$7.10 from its previous closing price. On the day, 0.79 million shares were traded. ORGN stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.43.
Ratios:
Our goal is to gain a better understanding of ORGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.48 and its Current Ratio is at 13.57. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 16, 2024, Upgraded its rating to Buy and sets its target price to $3 from $1.35 previously.
On August 11, 2023, Craig Hallum Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.
On October 14, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $7.Credit Suisse initiated its Outperform rating on October 14, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 20 ’24 when Hickox John sold 200 shares for $1.59 per share. The transaction valued at 318 led to the insider holds 533,411 shares of the business.
Hickox John sold 200 shares of ORGN for $288 on Aug 22 ’24. The Director now owns 533,211 shares after completing the transaction at $1.44 per share. On Jun 25 ’24, another insider, Heidenmark Cook Pia Johanna, who serves as the Director of the company, sold 4,640 shares for $0.98 each. As a result, the insider received 4,568 and left with 118,558 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 226700656 and an Enterprise Value of 90846568. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.16 while its Price-to-Book (P/B) ratio in mrq is 0.54. Its current Enterprise Value per Revenue stands at 2.667 whereas that against EBITDA is -1.601.
Stock Price History:
Over the past 52 weeks, ORGN has reached a high of $1.73, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 45.80%, while the 200-Day Moving Average is calculated to be 76.72%.
Shares Statistics:
The stock has traded on average 1.87M shares per day over the past 3-months and 3002370 shares per day over the last 10 days, according to various share statistics. A total of 145.71M shares are outstanding, with a floating share count of 122.07M. Insiders hold about 16.25% of the company’s shares, while institutions hold 16.95% stake in the company. Shares short for ORGN as of 1722384000 were 4180891 with a Short Ratio of 2.24, compared to 1719532800 on 10583283. Therefore, it implies a Short% of Shares Outstanding of 4180891 and a Short% of Float of 3.2899998.
